Edesa Biotech, Inc. Research And Development Expense

Quick Answer

Edesa Biotech, Inc. reported Research And Development Expense of $3.67 million for the year ending 2025.

  • Edesa Biotech, Inc. showed an increase of +27.3% in Research And Development Expense from 2024 to 2025.
  • This data is from Edesa Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on December 12, 2025.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2013: $203.4 thousand | Q4 2013: $548.2 thousand | Q1 2014: $733.1 thousand | Q2 2014: $543.2 thousand | Q4 2014: $418.8 thousand | Q1 2015: $281.6 thousand | Q2 2015: $129.7 thousand | Q4 2015: $288.8 thousand | Q1 2016: $309.1 thousand | Q2 2016: $470.1 thousand | Q4 2016: $460.9 thousand | Q1 2017: $329.4 thousand | Q2 2017: $536.2 thousand | Q4 2017: $631.0 thousand | Q1 2018: $493.9 thousand | Q2 2018: $298.2 thousand | Q4 2018: $257.4 thousand | Q1 2019: $111.7 thousand | Q2 2019: $502.9 thousand | Q4 2019: $528.0 thousand | Q1 2020: $502.8 thousand | Q2 2020: $1.14 million | Q4 2020: $1.38 million | Q1 2021: $7.98 million | Q2 2021: $4.46 million | Q4 2021: $3.95 million | Q1 2022: $3.04 million | Q2 2022: $4.55 million | Q4 2022: $1.36 million | Q1 2023: $1.46 million | Q2 2023: $1.03 million | Q4 2023: $704.5 thousand | Q1 2024: $1.18 million | Q2 2024: $897.3 thousand | Q4 2024: $1.02 million | Q1 2025: $484.3 thousand | Q2 2025: $939.1 thousand | Q4 2025: $1.12 million.
  • Over the full 13 years of available data (2013 to 2025), Edesa Biotech, Inc.'s Research And Development Expense has grown by 81.8%.
  • Historical annual values: Fiscal year 2025: $3.67 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $4.79 million | Fiscal year 2022: $13.34 million | Fiscal year 2021: $17.95 million | Fiscal year 2020: $3.33 million | Fiscal year 2018: $2.09 million | Fiscal year 2017: $1.97 million | Fiscal year 2016: $1.73 million | Fiscal year 2015: $1.03 million | Fiscal year 2014: $178.3 thousand | Fiscal year 2014: $2.46 million | Fiscal year 2013: $2.02 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: